Abstract

BackgroundNovel telemedicine platforms have expanded access to critical retinal screening into primary care settings. This increased access has contributed to improved retinal screening uptake for diabetic patients, particularly those treated in Federally Qualified Health Centers (‘safety net’ clinics). The aim of this study was to understand how the implementation of telemedical screening for diabetic retinopathy within primary care settings is improving the delivery of critical preventative services, while also introducing changes into clinic workflows and creating additional tasks and responsibilities within resource-constrained clinics.MethodsA qualitative approach was employed to track workflows and perspectives from a range of medical personnel involved in the telemedicine platform for diabetic retinopathy screening and subsequent follow-up treatment. Data were collected through semi-structured interviews and participant observation at three geographically-dispersed Federally Qualified Health Centers in California. Qualitative analysis was performed using standard thematic analytic approaches within a qualitative data analysis software program.ResultsThe introduction of telemedicine platforms, such as diabetic retinopathy screening, into primary care settings is creating additional strain on medical personnel across the diabetes eye care management spectrum. Central issues are related to scheduling patients, issuing referrals for follow-up care and treatment, and challenges to improving adherence to treatment and diabetes management. These issues are overcome in many cases through workarounds, or when medical staff work outside of their job descriptions, purview, and permission to move patients through the diabetes management continuum.ConclusionsThis study demonstrates how the implementation of a novel telemedical platform for diabetic retinopathy screening contributes to the phenomenon of workarounds that account for additional tasks and patient volume. These workarounds should not be considered a sustainable model of health care delivery, but rather as an initial step to understanding where issues are and how clinics can adapt to the inclusion of telemedicine and ultimately increase access to care. The presence of workarounds suggests that as telemedicine is expanded, adequate resources, as well as collaborative, cross-sectoral co-design of new workflows must be simultaneously provided. Systematic bolstering of resources would contribute to more consistent success of telemedicine screening platforms and improved treatment and prevention of disease-related complications.

Highlights

  • Novel telemedicine platforms have expanded access to critical retinal screening into primary care settings

  • While telemedicine solutions for screening, diagnostics, and treatment have been implemented in many clinical settings, such as emergency rooms [1], dermatology [2], psychiatry [3], and pediatrics [4], the focus of this study is on screening for retinal eye diseases that arise as a result of complications from advanced diabetes, or diabetic retinopathy screening (DR screening)

  • To better understand utilization gaps that relate to failure to exercise treatment options, we looked at patients who were found to have vision-threatening diabetic retinopathy (VTDR) through screening in Federally Qualified Health Centers and the staff members responsible for screening, issuing referrals, and performing treatment for VTDR

Read more

Summary

Introduction

Novel telemedicine platforms have expanded access to critical retinal screening into primary care settings This increased access has contributed to improved retinal screening uptake for diabetic patients, those treated in Federally Qualified Health Centers (‘safety net’ clinics). Despite the fact that timely detection and treatment of VTDR can be highly effective at preventing vision loss, VTDR persists as the main cause of blindness among working-age adults [5,6,7]. This is an issue of access both to screening and to subsequent treatment. Considering the burgeoning population of people with diabetes, addressing the gaps that exist between retinal screening and diabetic retinopathy treatment is crucial

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call